The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Bristol-Myers Squibb Co. (NYSE: BMY) closed at $40.11 down -0.84% from its previous closing price of $40.45. In other words, the price has decreased by -$0.84 from its previous closing price. On the day, 9.13 million shares were traded. BMY stock price reached its highest trading level at $40.66 during the session, while it also had its lowest trading level at $40.03.
Ratios:
For a deeper understanding of Bristol-Myers Squibb Co.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.41 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.50. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 1.11. In the meantime, Its Debt-to-Equity ratio is 3.48 whereas as Long-Term Debt/Eq ratio is at 3.10.
On February 06, 2024, Redburn Atlantic Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $77 to $54.
BofA Securities Downgraded its Buy to Neutral on January 03, 2024, whereas the target price for the stock was revised from $68 to $60.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 05 ’23 when BOERNER CHRISTOPHER S. bought 2,000 shares for $49.78 per share. The transaction valued at 99,560 led to the insider holds 82,672 shares of the business.
BOERNER CHRISTOPHER S. bought 3,071 shares of BMY for $150,049 on Nov 28 ’23. The Chief Executive Officer now owns 79,384 shares after completing the transaction at $48.86 per share. On Nov 20 ’23, another insider, Samuels Theodore R. II, who serves as the Director of the company, bought 8,500 shares for $49.81 each. As a result, the insider paid 423,385 and bolstered with 35,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMY now has a Market Capitalization of 81205633024 and an Enterprise Value of 129050632192. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.79 while its Price-to-Book (P/B) ratio in mrq is 4.93. Its current Enterprise Value per Revenue stands at 2.834 whereas that against EBITDA is 7.102.
Stock Price History:
Over the past 52 weeks, BMY has reached a high of $65.38, while it has fallen to a 52-week low of $39.63. The 50-Day Moving Average of the stock is -6.63%, while the 200-Day Moving Average is calculated to be -19.46%.
Shares Statistics:
For the past three months, BMY has traded an average of 14.95M shares per day and 18890440 over the past ten days. A total of 2.03B shares are outstanding, with a floating share count of 2.03B. Insiders hold about 0.07% of the company’s shares, while institutions hold 78.80% stake in the company. Shares short for BMY as of 1718323200 were 30293592 with a Short Ratio of 2.03, compared to 1715731200 on 28265554. Therefore, it implies a Short% of Shares Outstanding of 30293592 and a Short% of Float of 1.5.
Dividends & Splits
According to the company, the forward annual dividend rate for BMY is 2.34, from 2.34 in the trailing year. Against a Trailing Annual Dividend Yield of 0.057849195The stock’s 5-year Average Dividend Yield is 3.32.
